Greek Pharma outlines immediate priorities to avert a collapse of the health care system

At a press conference in Athens last week, the President of the Greek research-based pharma association SFEE, Konstantinos Frouzis, called for immediate actions by the government to support patients, stating that SFEE can act as an institutional consultant of the government. In this way, the effectiveness of government interventions can be maximized, without jeopardizing citizens’ access to medicines.

Given the current economic circumstances and improper management by the State, many insured patients have for a long time been left without the treatments they need. It is now clear that EOPYY’s financing is grossly inadequate and poorly designed, thus failing to meet the increased health care needs of the insured.

“The State has once again failed to fulfill its obligations, and its debts to pharmaceutical companies are several years past due, while the haircut on the government bonds that we have been given in settlement of such debts has been, to say the least, unfair. We have all witnessed the results of these actions. Most of all, the chronically or severely ill patients, are cruelly hit by the State’s failure to provide them with what they are entitled to," said Mr Frouzis.